Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1215347.RArMo3rb8ImZlpfIBy_WbP26u4q81op5LW-y2_66EdEQA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1215347.RArMo3rb8ImZlpfIBy_WbP26u4q81op5LW-y2_66EdEQA130_assertion type Assertion NP1215347.RArMo3rb8ImZlpfIBy_WbP26u4q81op5LW-y2_66EdEQA130_head.
- NP1215347.RArMo3rb8ImZlpfIBy_WbP26u4q81op5LW-y2_66EdEQA130_assertion description "[Aberrant epidermal growth factor receptor (EGFR) signaling in non-small cell lung cancer (NSCLC) is linked to tumor progression, metastasis and poor survival rates.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1215347.RArMo3rb8ImZlpfIBy_WbP26u4q81op5LW-y2_66EdEQA130_provenance.
- NP1215347.RArMo3rb8ImZlpfIBy_WbP26u4q81op5LW-y2_66EdEQA130_assertion evidence source_evidence_literature NP1215347.RArMo3rb8ImZlpfIBy_WbP26u4q81op5LW-y2_66EdEQA130_provenance.
- NP1215347.RArMo3rb8ImZlpfIBy_WbP26u4q81op5LW-y2_66EdEQA130_assertion SIO_000772 25174397 NP1215347.RArMo3rb8ImZlpfIBy_WbP26u4q81op5LW-y2_66EdEQA130_provenance.
- NP1215347.RArMo3rb8ImZlpfIBy_WbP26u4q81op5LW-y2_66EdEQA130_assertion wasDerivedFrom befree-2016 NP1215347.RArMo3rb8ImZlpfIBy_WbP26u4q81op5LW-y2_66EdEQA130_provenance.
- NP1215347.RArMo3rb8ImZlpfIBy_WbP26u4q81op5LW-y2_66EdEQA130_assertion wasGeneratedBy ECO_0000203 NP1215347.RArMo3rb8ImZlpfIBy_WbP26u4q81op5LW-y2_66EdEQA130_provenance.